Font Size: a A A
Keyword [Endometrial Carcinoma]
Result: 181 - 200 | Page: 10 of 10
181. Expression Of VEGF, COX-2 And HIF-1α And Their Significance In Endometrial Carcinoma
182. Analysis Of Prognostic Factors In Endometrial Carcinoma
183. Expression Of Syndecan-1 And E-cadherin In Endometrial Carcinoma Tissue
184. Expression Of Human Luteinizing Hormone/human Chorionic Gonadotropin Receptor In Premenopausal And Postmenopausal Endometrial Carcinoma
185. Expression And Clinical Significance Of PTEN And VEGF In Endometrial Carcinoma
186. Significance And Expression Of STAT3 And VEGF In Endometrial Carcinoma By Using Tissue Chip Technique
187. Study On Correlativity Between PTEN Gene Mutation, Protein Expression And Endometrial Cancer
188. Analysis Of Risk Factors Affecting Lymph Node Metastasis In Endometrial Carcinoma
189. Ursolic Acid Induced Apoptosis In Endometrial Carcinoma HHUA Cells
190. Evaluation Of Dynamic MR Imaging And DWI Of 3T MR In Endometrial Carcinoma
191. Endometrial Carcinoma Therapy
192. Meta-analysis Of Adjuvant Progesterone Therapy In Stage Ⅰ And Ⅱ Endometrial Carcinoma
193. Value Of MRI In The Assessment Of Invasion By Endometrial Carcinoma
194. Analysis Of Diagnosis And Therapy About 95 Cases Of Endometrial Carcinoma
195. Expression Of LeY, FUT1 And FUT4 In Endometrial Carcinoma
196. A Study Of The Precursor Lesion Of Type Ⅱ Endometrial Carcinoma
197. Pilot Study On The Effect Of Bone Marrow Stem Cells Transplantation Of Allochthonous On Inducing Endometrial Carcinoma In Mice By 17β-Estradiol
198. Expression And Clinical Significance Of Mesothelin MRNA In Endometrial Carcinoma
199. Expression And Significance Of Metallothionein In Endometrial Carcinoma
200. The Effects Of SiRNA Target VEGF On Both The Expression Of VEGF And The Cells Proliferation Of Endometrial Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to